Table 2.
Correlation between clinicopathological features and expression of TAZ in retinoblastoma patients
| Feature | All patients n = 43, n (%) | Expression of TAZ | P value | |
|---|---|---|---|---|
| High | Low | |||
| Age at presentation (y) | 28 | 15 | 0.602 | |
| < 5 y | 39 (90.7) | 26 | 13 | |
| ≥ 5 y | 4 (9.3) | 2 | 2 | |
| Gender | 28 | 15 | 0.338 | |
| Male | 18 (41.9) | 10 | 8 | |
| Female | 25 (58.1) | 18 | 7 | |
| Tumor enucleated location | 28 | 15 | 1.000 | |
| Right | 25 (58.1) | 16 | 9 | |
| Left | 18 (41.9) | 12 | 6 | |
| cTNM classification | ||||
| T classification | 28 | 15 | 0.116 | |
| T1 + 2 | 24 | 13 | 11 | |
| T3 + 4 | 19 | 15 | 4 | |
| N classification | 28 | 15 | 0.013* | |
| N0 | 20 | 9 | 11 | |
| N1 + 2 | 23 | 19 | 4 | |
| cTNM stage | 28 | 15 | 0.184 | |
| I + II | 14 | 7 | 7 | |
| III + IV | 29 | 21 | 8 | |
| Largest tumor base (mm) | 28 | 15 | 0.045* | |
| ≤ 15 mm | 28 (65.1) | 15 | 13 | |
| > 15 mm | 15 (34.9) | 13 | 2 | |
| Tumor thickness (mm) | 28 | 15 | 0.750 | |
| ≤ 10 mm | 25 (58.1) | 17 | 8 | |
| > 10 mm | 18 (41.9) | 11 | 7 | |
| Differentiation | 28 | 15 | 0.019* | |
| Well and moderate | 24 (55.8) | 12 | 12 | |
| Poorly | 19 (44.2) | 16 | 3 | |
*P < 0.05